Cantor Fitzgerald raises Robinhood stock price target to $100 on crypto push

Published 01/07/2025, 14:06
© Reuters

Investing.com - Cantor Fitzgerald has raised its price target on Robinhood Markets (NASDAQ:HOOD) to $100.00 from $89.00 while maintaining an Overweight rating on the stock. The target comes as HOOD trades near its 52-week high of $94.24, having delivered an impressive 310% return over the past year. InvestingPro analysis suggests the stock is currently trading above its Fair Value.

The firm cited Robinhood’s deeper expansion into cryptocurrency as the primary driver behind the increased target, noting that new product launches in this space could provide "meaningful revenue and earnings runway in the future." This optimism appears justified, with InvestingPro data showing strong revenue growth of 59.65% and positive earnings of $1.80 per share over the last twelve months.

Cantor Fitzgerald’s higher price target is primarily driven by an increased target multiple applied to Robinhood shares, which the firm believes "is warranted given the product roadmap."

The research firm emphasized that Robinhood remains a "must-own name in the sector" as the company continues to diversify its offerings beyond traditional stock trading.

Robinhood has been strategically expanding its cryptocurrency capabilities as part of its broader effort to attract users seeking exposure to digital assets alongside conventional investment options.

In other recent news, Robinhood Markets has been making headlines with several key developments. Mizuho (NYSE:MFG) raised its price target for Robinhood to $99, citing the company’s rapid product innovation and recent events like "To Catch a Token" as pivotal factors. This comes as Robinhood launches tokenized U.S. stocks for European Union customers, allowing them to trade over 200 U.S. stocks and ETFs through a partnership with blockchain firm Arbitrum. Meanwhile, Goldman Sachs increased its price target to $91, noting mixed trading volumes but maintaining a positive long-term outlook due to Robinhood’s ongoing product launches and geographic expansion. Compass Point also raised its price target to $96, highlighting Robinhood’s strong performance and growth trends in areas like tokenized stocks and blockchain efficiencies. In related news, former Robinhood executive Dheerja Kaur has been appointed as the first Chief Product Officer at Hims & Hers Health, bringing her experience in product development and revenue growth to the healthcare platform. These recent developments underscore Robinhood’s dynamic approach to expanding its offerings and market presence.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.